effects earlier across therapeutic areas in digital trials.

- Capture meaningful quality-of-life outcomes in chronic and acute conditions.

- Bring treatments to market faster across neurological, psychiatric, and cognitive health.

- Enable real-time, data-driven health monitoring through apps and platforms.

Adalyon's AI platform includes an API for compiling custom speech biomarkers, a patient app for low-friction guided voice journaling and Ayda Insights analytics service for clinicians and trial management to incorporate insights into practice.